HighGravityDataHumana — Feb 11, 2025 release
Fiscal 2024 fourth-quarter results · 8-K Item 2.02 · Exhibit 99.1 · 0000049071-25-000004
Showing in the filing
Weighted Avg. Share Count for Diluted EPS
“approximately 121.5 million”
Period
FY2025
Measure
GAAP-tied
Source
Guidance table
All guidance in this release · 24
Adjusted FY 2025 EPS for FY2025
“at least in line with 2024 results”
GAAP EPS for FY2025
“approximately $15.88”
GAAP EPS for FY2025
“approximately $15.88”
Adjusted (non-GAAP) EPS for FY2025
“approximately $16.25”
Adjusted EPS for FY2025
“approximately $16.25”
Diluted earnings per share (Adjusted non-GAAP) for FY2025
“approximately $16.25”
Individual Medicare Advantage annual members… for FY2025
“approximately 550,000, or approximately 10 percent”
Diluted earnings per common share - GAAP for FY2025
“approximately $15.88”
Total Revenues Consolidated - GAAP for FY2025
“$126 billion to $128 billion”
Total Revenues Insurance segment - GAAP for FY2025
“$121 billion to $123 billion”
Total Revenues CenterWell segment - GAAP for FY2025
“$20.5 billion to $21.5 billion”
Change in year-end medical membership from p… for FY2025
“Decline of approximately 550,000”
Change in year-end medical membership from p… for FY2025
“Relatively flat”
Change in year-end medical membership from p… for FY2025
“Growth of approximately 200,000”
Change in year-end medical membership from p… for FY2025
“Growth within 175,000 to 250,000 range”
Benefit Ratio Insurance segment - GAAP for FY2025
“90.1% to 90.5%”
Operating Cost Ratio - Consolidated GAAP for FY2025
“11.3% to 11.7%”
Segment Results: Insurance segment income fr… for FY2025
“GAAP: $1.5 billion to $2.0 billion”
CenterWell segment income from operations - … for FY2025
“$1.0 billion to $1.5 billion”
CenterWell segment income from operations - … for FY2025
“$1.2 billion to $1.7 billion”
Effective Tax Rate - GAAP for FY2025
“approximately 25.0%”
Weighted Avg. Share Count for Diluted EPS for FY2025
“approximately 121.5 million”
Cash flows from operations - GAAP for FY2025
“$2.4 billion to $2.9 billion”
Capital expenditures for FY2025
“approximately $650 million”
Exhibit 99.1 · the passage around this item
… earlier in the release
Segment Results Insurance segment income from operations GAAP: $1.5 billion to $2.0 billion CenterWell segment Non-GAAP income from operations excludes the projected impact of segment depreciation and amortization. CenterWell segment income from operations GAAP: $1.0 billion to $1.5 billion Non-GAAP: $1.2 billion to $1.7 billion Effective Tax Rate GAAP: approximately 25.0% Weighted Avg. Share Count for Diluted EPS approximately 121.5 million Cash flows from operations GAAP: $2.4 billion to $2.9 billion Capital expenditures approximately $650 million 14 Humana Inc. Statistical Schedules and Supplementary Information 4Q24 Earnings Release S-1 Humana Inc. Statistical Schedules and Supplementary Information 4Q24 Earnings Release (S-3) Summary of Results - Consolidated and Segment Quarter and FY (S-4) Consolidated Statements of Income - Quarter and FY (S-5) Consolidated Balance Sheets (S-6) Consolidated Statements of Cash Flows - FY (S-7) - (S-8) Consolidating Statements of Income - Quarter (S-9) - (S-10) Consolidating Statements of Income - FY (S-11) Membership Detail (S-12) Premiums and Services Revenue Detail (S-13) - (S-15) CenterWell Segment - Pharmacy Solutions, Primary Care, & Home Solutions (S-16) Footnotes S-2 Humana Inc. Summary of Results ($ in millions, except per share amounts) 4Q24 (a) 4Q23 (a) FY 2024 (a) FY 2023 (a) CONSOLIDATED Revenues $29,213 $26,462 $117,761 $106,374 Revenues - Adjusted (non-GAAP) $29,199 $25,734 $117,210 $102,645 Pretax results ($862) ($591) $1,721 $3,383 Pretax results - Adjusted (non-GAAP) ($296) $79 $2,702 $4,369 (Net loss per share) EPS ($5.76) ($4.42) $9.98 $20.00 (Net loss per sh
later in the release …
the item shown at left
other guidance in this release
Text is the filed exhibit, verbatim.